Serum procalcitonin does not differentiate between infection and disease flare in patients with systemic lupus erythematosus

Lupus

Volumn 20, Issue 2, 2011, Pages 125-130

  Lanoix, J P ^a   Bourgeois, A M ^a   Schmidt, J ^a   Desblache, J ^a   Salle, V ^a   Smail, A ^a   Maziere J C ^a   Betsou, F ^a   Choukroun, G ^a   Duhaut, P ^a   Ducroix, J P ^a  

^a AMIENS UNIVERSITY HOSPITAL   (France)

Author keywords

adult; flare; infection; procalcitonin; systemic lupus erythematosus

Indexed keywords

C REACTIVE PROTEIN; PROCALCITONIN;

ADULT; AGED; ARTICLE; BACTERIAL INFECTION; CONTROLLED STUDY; CORRELATIONAL STUDY; DISEASE EXACERBATION; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HOSPITALIZATION; HUMAN; IMMUNOFLUORESCENCE; MAJOR CLINICAL STUDY; MALE; PREDICTIVE VALUE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RETROSPECTIVE STUDY; SCORING SYSTEM; SEX DIFFERENCE; SLEDAI SCORE; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADOLESCENT; ADULT; AGED; BACTERIAL INFECTIONS; CALCITONIN; DISEASE PROGRESSION; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; PROTEIN PRECURSORS; RETROSPECTIVE STUDIES; SEX FACTORS; YOUNG ADULT;

EID: 79953322637     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1177/0961203310378862     Document Type: Article

References (18)

1. Hind CR, Ng SC, Feng PH, Pepys MB. Serum CRP measurement in the detection of intercurrent infection Oriental patients with systemic lupus erythematosus. Ann Rheum Dis 1985; 44: 260-261. (Pubitemid 15112840)
2. Al-Mekaimi A, Malaviya AN, Serebour F, et al. Serological characteristics of SLE from a hospital-based rheumatology clinic in Kuwait. Lupus 1997; 6: 668-674. (Pubitemid 27480661)
3. Williams RC, Harmon ME, Burlingame R, Du Clos TW. Studies of serum CRP in SLE. J Rheum 2005; 32: 454-461.
4. Ferriere F. Procalcitonin, a new marker for bacterial infection. Ann Biol Clin 2000; 58: 49-59. (Pubitemid 30096700)
5. Schwarz S, Bertram M, Schwab S, Andrassy K, Hacke W. Serum procalcitonin levels in bacterial and abacterial meningitis. Crit Care Med 2000; 28: 1828-1832. (Pubitemid 30428738)
6. Rau B, Steinbach G, Gansauge F, Mayer JM, Grünert A, Beger HG. The potential role of procalcitonin and interleukin 8 in the prediction of infected necrosis in acute pancreatitis. Gut 1997; 41: 832-840. (Pubitemid 28023189)
7. Delèvaux I, André M, Colombier M, et al. Can procalcitonin measurement help in differentiating between bacterial infection and other kinds of inflammatory processes? Ann Rheum Dis 2003; 62: 337-340.
8. Tamaki K, Kogata Y, Sugiyama D, et al. Diagnostic accuracy of serum procalcitonin concentrations for detecting systemic bacterial infection in patients with systemic autoimmune diseases. J Rheum 2008; 35: 114-119.
9. Scirè CA, Cavagna L, Perroti C, Bruschi E, Caporali R, Montecucco C. Diagnostic value of procalcitonin measurement in febrile patients with systemic autoimmune diseases. Clin Exp Rheum 2006; 24: 123-128. (Pubitemid 43826859)
10. Tan ME, Cohen AS, Fries JF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 11: 1271-1277. (Pubitemid 13221242)
11. Shin KC, Lee YJ, Kang SW, et al. Serum procalcitonin measurement for detection of intercurrent infection in febrile patients with SLE. Ann Rheum Dis 2001; 60: 988-989. (Pubitemid 32885681)
12. Eberhard OK, Haubitz M, Brunkhorst FM, Kliem V, Koch KM, Brunkhorst R. Usefulness of procalcitonin for differentiation between activity of systemic autoimmune disease (systemic lupus erythematosus/systemic antineutrophil cytoplasmic antibody-associated vasculitis) and invasive bacterial infection. Arthritis Rheum 1997; 40: 1250-1256. (Pubitemid 27430136)
13. Quintana G, Medina Y, Rojas C, et al. The use of procalcitonin determinations in evaluation of systemic lupus erythematosus. J Clin Rheum 2008; 14: 138-142.
14. Brinkhorst R, Eberhardt OK, Haubitz M, Brunkhorst FM. Procalcitonin for discrimination between activity of systemic autoimmune disease and systemic bacterial infection. Intensive Care Med 2000; 26: S199-201.
15. Gaubitz M. Epidemiology of connective tissue disorders. Rheumatology 2006; 45: iii3-4.
16. Cervera R. Systemic lupus erythematosus in Europe at the change of the millennium: lessons from the ''Euro-Lupus Project''. Autoimmun Rev 2006; 5: 180-186.
17. Barassi A, Pallotti F, Melzi d'Eril G. Biological variation of procalcitonin in healthy individuals. Clin Chem 2004; 50: 1878.
18. Schmidt J, Duhaut P, Bourgeois AM, et al. GRACG. Procalcitonin at the onset of giant cell arteritis and polymyalgia rheumatica: the GRACG prospective study. Rheumatology 2009; 48: 158-159.